NCT00711607View on ClinicalTrials.gov

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2007

Primary Completion Date

September 1, 2007

Study Completion Date

September 1, 2007

Conditions

Healthy

Interventions

DRUG

nomegestrol acetate and estradiol

Group 1: one tablet of 2.5 mg NOMAC-E2 and 1.5 mg E2 per day on days 1-24 and day 35; Group 2: one tablet of 2.5 mg NOMAC-E2 and 1.5 mg E2 per day on days 1-24 followed by one Placebo tablet on day 35

All Listed Sponsors

collaborator

CRS Mannheim GmbH

UNKNOWN

lead

Organon and Co

INDUSTRY

NCT00711607 - A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822) | Biotech Hunter | Biotech Hunter